CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
CVI Accepts, published online ahead of print on 21 November 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00336-07v1
15/2/182    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clutterbuck, E. A.
Right arrow Articles by Pollard, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clutterbuck, E. A.
Right arrow Articles by Pollard, A. J.
Clin. Vaccine Immunol. doi:10.1128/CVI.00336-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Serotype specific and age dependent generation of pneumococcal polysaccharide specific memory B cells and antibody in response to immunization with a pneumococcal conjugate vaccine

Elizabeth A. Clutterbuck*, Sarah Oh, Mainga Hamaluba, Sharon Westcar, Peter C. L. Beverley, and Andrew J. Pollard

University of Oxford, Dept. of Paediatrics, Oxford, Oxfordshire, UK; Edward Jenner Institute for Vaccine Research, Compton, Berkshire, UK

* To whom correspondence should be addressed. Email: elizabeth.clutterbuck{at}paediatrics.ox.ac.uk.


   Abstract

Glycoconjugate vaccines have dramatically reduced encapsulated bacterial diseases in toddlers under 2 years of age but vaccine-induced antibody levels in this age group wane rapidly. We immunized adults and 12 month old toddlers with heptavalent pneumococcal conjugate vaccine to determine differences in B cell and antibody responses.

Adults and 12-month old toddlers received a pneumococcal conjugate vaccine. Toddlers received a second dose at 14-months of age. Frequencies of diphtheria and serotypes 4, 14 and 23F polysaccharide specific plasma cells and memory B cells were determined by ELISPOT.

Toddlers had no pre-existing polysaccharide specific memory B-cells or serum IgG antibody, but good diphtheria specific memory responses. Plasma cell and memory B cell frequency increased by day 7 (p=<0.0001) in adults and toddlers following a single dose of conjugate, but polysaccharide responses were significantly lower in toddlers than adults (p=0.009 to <0.001). IgM dominated toddler antibody responses and class switching to IgG was serotype dependent. A second dose of vaccine enhanced antibody and memory B cell responses in toddlers but not the ex vivo plasma cell response.

Two doses of pneumococcal conjugate vaccine are required in toddlers to generate memory B cell frequencies and antibody class switching for each pneumococcal polysaccharide equivalent to that seen in adults.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.